ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis.

Journal: Cancer Cell

Published: 2020-03-16

DOI: 10.1016/j.ccell.2020.02.006

Affiliations: 23

Authors: 28

Go to article
Institutions Share
Xiangya Hospital, CSU, China 0.39
Hunan Provincial Key Laboratory for Skin Tumor and Psoriasis at Xiangya Hospital, CSU, China 0.08
Hunan Provincial Engineering Research Center of Skin Health and Disease at Xiangya Hospital, CSU, China 0.08
Hunan Cancer Hospital, CSU, China 0.07
School of Life Sciences, CSU, China 0.06
McGovern Medical School, UTHealth, United States of America (USA) 0.05
HuaJia Biomedical Intelligence, China 0.04
Institute of Dermatology / Hospital for Skin Disease, CAMS & PUMC, China 0.04
The Third Affiliated Hospital, SYSU, China 0.04
Wuhan Union Hospital, HUST, China 0.04
Department of Pathology and Laboratory Medicine, Penn, United States of America (USA) 0.04
Shanghai Jiao Tong University School of Medicine (SJTUSM), China 0.02
Graduate Institute of Biomedical Sciences, CMU, Taiwan 0.01
Department of Biotechnology, Asia University, Taiwan 0.01
Center for Molecular Medicine, CMU, Taiwan 0.01
State Key Laboratory of Chemo/Biosensing and Chemometrics, HNU, China 0.01
Molecular Science and Biomedicine Laboratory (MBL), HNU, China 0.01
Collaborative Innovation Center for Chemistry and Molecular Medicine, HNU, China 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER